View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
October 12, 2011

Cardiac treats first patient in Titan II study

Cardiac Dimensions has treated the first patient in a clinical trial of its carillon mitral contour system, a novel therapy for treating heart failure patients suffering from functional mitral regurgitation.

Cardiac Dimensions has treated the first patient in a clinical trial of its carillon mitral contour system, a novel therapy for treating heart failure patients suffering from functional mitral regurgitation.

The mitral contour system consists of a proprietary, implantable device with a percutaneous catheter delivery system.

The one-year, follow-up, prospective, single-arm Titan II clinical trial is intended to further evaluate an enhanced version of the carillon system as a treatment for heart failure.

The initial 53-patient Titan trial demonstrated relief from functional mitral regurgitation and improvements in functional capacity and quality of life compared to a contemporaneously-enrolled control group.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Hospital Management